Search research articles
Contact Us
Filters
Showing results (91-100 of 108) with videos related to
Page
of 11
Sort By:
Clinical Rheumatology
|
January 10, 2020
Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease
Carmel J W Stock, Angelo De Lauretis, Dina Visca, et al.
Journal of Personalized Medicine
|
February 25, 2025
Dupilumab Effectiveness in Patients with Severe Allergic Asthma Non-Responsive to Omalizumab
Diego Bagnasco, Benedetta Bondi, Luisa Brussino, et al.
Respirology (Carlton, Vic.)
|
December 18, 2020
Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression
Carmel J W Stock, Rachel K Hoyles, Cecile Daccord, et al.
The European Respiratory Journal
|
April 18, 2020
Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact
Martina Bonifazi, Nicola Sverzellati, Eva Negri, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
February 8, 2020
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network
Giovanni Battista Migliori, Simon Tiberi, Alimuddin Zumla, et al.
Biomedicines
|
February 24, 2024
Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life Perspective
Marco Caminati, Matteo Maule, Roberto Benoni, et al.
Respiratory Medicine
|
June 13, 2025
ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up
Laura Pini, Marco Caminati, Matteo Maule, et al.
Journal of Clinical Medicine
|
May 25, 2024
Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study
Laura Pini, Diego Bagnasco, Bianca Beghè, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 16, 2025
Profiling Blood Hypereosinophilia in Patients on Dupilumab Treatment for Respiratory Conditions: A Real-Life Snapshot
Marco Caminati, Matteo Maule, Diego Bagnasco, et al.
Frontiers in Medicine
|
November 16, 2020
Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid)
Bahaa Abu-Raya, Giovanni Battista Migliori, Miguel O'Ryan, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 108) with videos related to
Sort By:
Page
of 11
Clinical Rheumatology
|
January 10, 2020
Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease
Carmel J W Stock, Angelo De Lauretis, Dina Visca, et al.
Journal of Personalized Medicine
|
February 25, 2025
Dupilumab Effectiveness in Patients with Severe Allergic Asthma Non-Responsive to Omalizumab
Diego Bagnasco, Benedetta Bondi, Luisa Brussino, et al.
Respirology (Carlton, Vic.)
|
December 18, 2020
Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression
Carmel J W Stock, Rachel K Hoyles, Cecile Daccord, et al.
The European Respiratory Journal
|
April 18, 2020
Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact
Martina Bonifazi, Nicola Sverzellati, Eva Negri, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
February 8, 2020
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network
Giovanni Battista Migliori, Simon Tiberi, Alimuddin Zumla, et al.
Biomedicines
|
February 24, 2024
Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life Perspective
Marco Caminati, Matteo Maule, Roberto Benoni, et al.
Respiratory Medicine
|
June 13, 2025
ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up
Laura Pini, Marco Caminati, Matteo Maule, et al.
Journal of Clinical Medicine
|
May 25, 2024
Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study
Laura Pini, Diego Bagnasco, Bianca Beghè, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 16, 2025
Profiling Blood Hypereosinophilia in Patients on Dupilumab Treatment for Respiratory Conditions: A Real-Life Snapshot
Marco Caminati, Matteo Maule, Diego Bagnasco, et al.
Frontiers in Medicine
|
November 16, 2020
Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid)
Bahaa Abu-Raya, Giovanni Battista Migliori, Miguel O'Ryan, et al.
Page
of 11